Navigation Links
Amgen Oncology Data to be Presented at ASCO Annual Meeting
Date:5/18/2011

(mPC)

(Abstract 4049) Poster on Saturday, June 4, 8:00 a.m. - 12:00 p.m., Hall A


  • A randomized, placebo-controlled phase II study of AMG 386 plus bevacizumab (Bev) and paclitaxel (P) or AMG 386 plus P as first-line therapy in patients (pts) with HER2-negative, locally recurrent or metastatic breast cancer (LR/MBC)

  • (Abstract 544) Poster on Monday, June 6, 1:00 p.m. - 5:00 p.m., Hall A


  • An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC)

  • (Abstract LBA7512) Poster Discussion on Monday, June 6, 2:00 p.m. - 6:00 p.m., E450aFor the latest updates on Amgen's presence at ASCO and other Amgen news, follow us on Twitter @Amgen.About XGEVAXGEVA is the first and only RANK Ligand inhibitor approved by the U.S. Food and Drug Administration (FDA) that is indicated for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. XGEVA is not indicated for the prevention of SREs in patients with multiple myeloma. XGEVA is the first novel bone metastases treatment for patients with advanced cancer in nearly a decade. Delivered as an every four week 120 mg subcutaneous injection, XGEVA provides a unique option for urologists and oncologists to prevent SREs in patients with advanced cancer.

    XGEVA is a fully human monoclonal antibody that binds to RANK Ligand, a protein essential for the formation, function and survival of osteoclasts (the cells that break down bone). XGEVA prevents RANK Ligand from activating its receptor, RANK, on the surface of osteoclasts, thereby decreasing bone destruction.

    The clinical program for XGEVA spanned more than 50 tumor types in more than 5,700 patients. In clinical trials, XGEVA demonstrated a clinically meaningful improvement
    '/>"/>

    SOURCE Amgen
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference
    2. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
    3. Amgen to Present at the Deutsche Bank 36th Annual Healthcare Conference
    4. Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
    5. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
    6. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
    7. Amgen to Webcast 2011 Business Review Meeting on April 21
    8. Amgen Announces Webcast of 2011 First Quarter Financial Results
    9. Amgen Establishes Commercial Operations in Brazil
    10. Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe
    11. Amgen Donates $1 Million to Help Japanese Disaster Victims
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/31/2014)... 2014 Imago BioSciences, Inc., a biotech ... million Series A financing led by Clarus Ventures ... team of accomplished investment and operating professionals dedicated ... round include Frazier Healthcare, Amgen Ventures, and Merck ... and Frazier Healthcare will join the company,s board ...
    (Date:10/31/2014)... , October 31, 2014 Investor-Edge ... (NASDAQ: NSPH ), Isis Pharmaceuticals Inc. (NASDAQ: ... HALO ), ACADIA Pharmaceuticals Inc. (NASDAQ: ... research on these five companies can be accessed at: ... 2014, the NASDAQ Composite ended at 4,566.14, up 0.37%, ...
    (Date:10/31/2014)... 31, 2014  Encision Inc. (OTCQB:ECIA), a medical device ... electrosurgical burns in minimally invasive surgery, today announced financial ... 30, 2014. The Company posted quarterly net ... of $414 thousand, or $(0.04) per share. These results ... net loss of $50 thousand, or $(0.01) per share, ...
    Breaking Medicine Technology:Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5Encision Reports Second Quarter Fiscal Year 2015 Results 2Encision Reports Second Quarter Fiscal Year 2015 Results 3Encision Reports Second Quarter Fiscal Year 2015 Results 4Encision Reports Second Quarter Fiscal Year 2015 Results 5
    ... for spine tumorsLAS VEGAS, Feb. 22 For orthopaedic researcher ... a personal as well as a professional mission. Her cousin ... remembers the incredible pain her cousin experienced when the cancer ... Keyak and her colleagues at the University of California, ...
    ... Health Secretary Everette James today ... million will be awarded from Pennsylvania,s share of ... focus on specific research priorities established and reviewed ... chaired by Secretary James. The priorities for 2008-09 ...
    Cached Medicine Technology:Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 2Breast Cancer Patients May Have a New Treatment Option When Cancer Spreads 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 2Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 3Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds 4
    (Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat Loss review ... fat loss program ever developed. It promises to provide users ... is no wonder after all that this has become the ... nutrition and workout fat loss program was created by Joel ... to the author of this fat loss system, the method ...
    (Date:10/31/2014)... Oaks, CA (PRWEB) October 31, 2014 ... tummy also has amazing health effects for practitioners. ... created by a Doctor of Science and Movement ... through his dedication to pelvic floor reeducation that ... of urinary incontinence, Diastasis Recti, Prolepses, etc. , ...
    (Date:10/31/2014)... 31, 2014 With all the preparations ... optometrist feels they may overlook one critical area – ... like concentration, school performance and even behavior. Typical children’s ... to identify progressive vision problems, and to address this ... a new initiative: The Awesome Eyes Student Vision Program. ...
    (Date:10/31/2014)... 31, 2014 Energy Textiles has recently ... new gear is now available online, and Energy Textile ... of Celliant infrared-active athletic gear over compression gear. , ... contract has been signed for Under Armour to provide ... next eight years. In light of this decision, Energy ...
    (Date:10/31/2014)... Sleep apnea may make it hard for you to remember ... left your house keys, a small study suggests. Tests ... ability -- called spatial memory -- was impaired when sleep ... stages of sleep weren,t affected. REM sleep is the deepest ... shown for the first time that sleep apnea, an increasingly ...
    Breaking Medicine News(10 mins):Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Sleep Apnea May Steal Some of Your Memory: Study 2
    ... challenges, experts say , , THURSDAY, April 30 (HealthDay News) -- ... health officials are already collecting information and ingredients with an ... though experts say there,s no guarantee such a shot -- ... agree it,s the logical next step. , There are ...
    ... Study Gives North Dakotans Access to Nursing Home, Assisted Living, ... Every Zip Code StatewideRICHMOND, Va., April 30 The cost ... a rate outpacing inflation, putting significant financial pressure on those ... Genworth Financial. At the same time, the current economic ...
    ... Study Gives New Hampshire Residents Access to Nursing Home, Assisted ... Nearly Every Zip Code StatewideRICHMOND, Va., April 30 The ... Hampshire is rising at a rate outpacing inflation, putting significant ... an annual study by Genworth Financial. At the same ...
    ... ANTIOCH, Ill., April 30 The World Health Organization ... April 27th. Meanwhile, health officials around the globe are ... demand for containing infectious disease has never been greater.One ... deadly germs: Intelligent Healthcare Displays. Responding to recommendations from ...
    ... Birner Dental Management Services, Inc. (Nasdaq: BDMS ... conduct a conference call to review first quarter 2009 results. ... include discussion of management,s expectations of future financial and operating ... 14, 2009 at 9:00 a.m. MT.Dial in to 1-866-283-8244; refer ...
    ... Residents Access to Nursing Home, Assisted Living, Home Care ... Zip Code StatewideRICHMOND, Va., April 30 The cost ... a rate outpacing inflation, putting significant financial pressure on ... annual study by Genworth Financial. At the same time, ...
    Cached Medicine News:Health News:Swine Flu Vaccine Still Months Away 2Health News:Swine Flu Vaccine Still Months Away 3Health News:Growth in North Dakota Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in North Dakota Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in North Dakota Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in New Hampshire Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in New Hampshire Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in New Hampshire Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:The Best Defense Against Swine Flu 2Health News:Growth of Long Term Care Costs Outpacing the Rate of Inflation in Minnesota, According to Annual Genworth Financial Study 2Health News:Growth of Long Term Care Costs Outpacing the Rate of Inflation in Minnesota, According to Annual Genworth Financial Study 3Health News:Growth of Long Term Care Costs Outpacing the Rate of Inflation in Minnesota, According to Annual Genworth Financial Study 4
    ... The cost-effective line of compact CO2 ... units feature an extremely accurate laser beam, ... lasers are especially advantageous for small operating ... office sites. Use of special contact tips ...
    ... ideal for small clinics and offices. Based ... combines the advantages of laser precision and ... Novapulse system delivers short-duration, high amplitude pulses ... is allowed to cool thus minimizing charring ...
    ... MD Super Pulse sealed CO2 surgical lasers ... by the experience and support services of ... surgical laser experience. All settings are available ... Ultra MD Super Pulse surgical lasers are ...
    ... System is a Q-switched 532 Nd Yag ... fluid output, lowering intraocular pressure. The Selecta ... produces a 3-nanosecond high-energy beam of light, ... as traditional argon laser therapy (ALT), but ...
    Medicine Products: